The study was conducted as a randomized crossover trial. Twelve healthy volunteers (6 males and 6 females,
aged 18–55 years) were recruited and informed consent was obtained. All subjects had body mass index in the
range 24–28, were non-smokers and had no history of alcohol or drug abuse. The study protocol was approved
by The University of Western Ontario Review Board for Health Sciences Research Involving Human Subjects,
London, Ontario, Canada. The study was carried out and data analyzed in accordance with the ‘‘Note
Guidance on the Investigation of Bioavailability and Bioequivalence’’ from the European Agency for the
Evaluation of Medicinal Committee for Proprietary Products.